Bridgewater Associates’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
Bridgewater Associates's AZN Position: Q3 2026 in Review
Bridgewater Associates opened a new position in AstraZeneca (AZN) in Q3 2026: 8,188 shares worth $1.32M. The stake represents 0.01% of the portfolio and ranks #792 among its holdings. This is a return to the name: Bridgewater Associates previously reported a position in AZN as recently as Q3 2025.
Bridgewater Associates first reported a position in AZN in Q2 2021 and has held it in 19 quarters since. The position peaked at $50.8M in Q1 2025. 1,441 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- Bridgewater Associates held 8,188 shares of AstraZeneca worth $1.32M as of Q3 2026.
- AstraZeneca was a new Bridgewater Associates position in Q3 2026.
- AstraZeneca made up 0.01% of Bridgewater Associates's portfolio in Q3 2026, its #792 holding.
- Bridgewater Associates first reported a position in AstraZeneca in Q2 2021 and has held it in 19 quarters since.
- Bridgewater Associates's AstraZeneca position peaked at $50.8M in Q1 2025.
- 1,441 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on Bridgewater Associates's 13F filing for Q3 2026, filed 16 Nov 2026.